These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8365043)

  • 1. Topical immunotherapy in the treatment of chronic severe alopecia areata.
    Shapiro J
    Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical immunotherapy of alopecia areata.
    van der Steen PH; Happle R
    Dermatol Clin; 1993 Jul; 11(3):619-22. PubMed ID: 8365044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact urticaria during topical immunotherapy.
    Tosti A; Guerra L; Bardazzi F
    Contact Dermatitis; 1989 Sep; 21(3):196-7. PubMed ID: 2791547
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
    Valsecchi R; Pansera B; Rossi A; Cainelli T
    G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata: topical immunotherapy--application and practical problems.
    MacDonald N; Wiseman MC; Shapiro J
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S36-40. PubMed ID: 11776938
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
    Choe SJ; Lee S; Pi LQ; Keum DI; Lee CH; Kim BJ; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):515-521.e4. PubMed ID: 29108907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of alopecia areata with diphencyprone].
    Suditu G; Toma A; Voiculescu M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
    Tosti A; Guidetti MS; Bardazzi F; Misciali C
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):199-201. PubMed ID: 8708020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata.
    Firooz A; Bouzari N; Mojtahed F; Pazoki-Toroudi H; Nassiri-Kashani M; Davoudi M; Dowlati Y
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):393-4. PubMed ID: 15857483
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sensitization therapy in severe alopecia areata].
    Tosti A; Guerra L; Capobianco C; Brasile GP
    G Ital Dermatol Venereol; 1988 Nov; 123(11):571-3. PubMed ID: 3254331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.